Search research articles
Contact Us
Filters
Showing results (21-30 of 69) with videos related to
Page
of 7
Sort By:
Geriatrics (Basel, Switzerland)
|
March 22, 2022
Economic Evaluation of Healthcare Resource Utilization and Costs for Newly Diagnosed Dementia-Related Psychosis
Nazia Rashid, James B Wetmore, Muna Irfan, et al.
International Journal of General Medicine
|
July 6, 2026
Trofinetide Use and Treatment Patterns Among Children Aged 2-4 Years with Rett Syndrome in the United States: A Retrospective Specialty Pharmacy Linked Claims Database Analysis
Nazia Rashid, Vinod Kumar Yakkala, Dilesh Doshi, et al.
American Journal of Alzheimer'S Disease and Other Dementias
|
March 25, 2022
Adverse Outcomes Associated With Off-Label Agents Used to Treat Dementia Patients With Psychosis: A Case-Control Medicare Database Study
Nazia Rashid, James B Wetmore, Muna Irfan, et al.
The Journal of Rheumatology
|
April 3, 2014
Effect of urate-lowering therapies on renal disease progression in patients with hyperuricemia
Gerald D Levy, Nazia Rashid, Fang Niu, et al.
The Permanente Journal
|
September 12, 2018
Urate-Lowering Therapy in Moderate to Severe Chronic Kidney Disease
Gerald Levy, Jiaxiao M Shi, T Craig Cheetham, et al.
Frontiers in Neurology
|
October 27, 2025
Prevalence, severity, frequency and healthcare resource use of epilepsy among individuals with Rett Syndrome: analysis of data from a Rett Center of Excellence
Nazia Rashid, Charles Ruetsch, Emily M LaFrance, et al.
Journal of Medical Economics
|
April 1, 2025
Healthcare resource utilization patterns among patients with Parkinson's disease psychosis and dementia: analysis of US Medicare beneficiaries treated with pimavanserin versus other-atypical antipsychotics or versus quetiapine
Krithika Rajagopalan, Daksha Gopal, Lambros Chrones, et al.
Journal of Medical Economics
|
June 13, 2026
Rett syndrome and real-world treatment patterns of trofinetide in the United States
Nazia Rashid, Vinod Kumar Yakkala, Safiuddin Shoeb Syed, et al.
Journal of Health Economics and Outcomes Research
|
June 15, 2026
Real-World Treatment Landscape of Individuals with Rett Syndrome Treated and Untreated with Trofinetide in the United States
Nazia Rashid, Vinod K Yakkala, Safiuddin S Syed, et al.
Journal of Managed Care & Specialty Pharmacy
|
March 1, 2021
Burden of illness among patients with dementia-related psychosis
Monica Frazer, Victor Abler, Rachel Halpern, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 69) with videos related to
Sort By:
Page
of 7
Geriatrics (Basel, Switzerland)
|
March 22, 2022
Economic Evaluation of Healthcare Resource Utilization and Costs for Newly Diagnosed Dementia-Related Psychosis
Nazia Rashid, James B Wetmore, Muna Irfan, et al.
International Journal of General Medicine
|
July 6, 2026
Trofinetide Use and Treatment Patterns Among Children Aged 2-4 Years with Rett Syndrome in the United States: A Retrospective Specialty Pharmacy Linked Claims Database Analysis
Nazia Rashid, Vinod Kumar Yakkala, Dilesh Doshi, et al.
American Journal of Alzheimer'S Disease and Other Dementias
|
March 25, 2022
Adverse Outcomes Associated With Off-Label Agents Used to Treat Dementia Patients With Psychosis: A Case-Control Medicare Database Study
Nazia Rashid, James B Wetmore, Muna Irfan, et al.
The Journal of Rheumatology
|
April 3, 2014
Effect of urate-lowering therapies on renal disease progression in patients with hyperuricemia
Gerald D Levy, Nazia Rashid, Fang Niu, et al.
The Permanente Journal
|
September 12, 2018
Urate-Lowering Therapy in Moderate to Severe Chronic Kidney Disease
Gerald Levy, Jiaxiao M Shi, T Craig Cheetham, et al.
Frontiers in Neurology
|
October 27, 2025
Prevalence, severity, frequency and healthcare resource use of epilepsy among individuals with Rett Syndrome: analysis of data from a Rett Center of Excellence
Nazia Rashid, Charles Ruetsch, Emily M LaFrance, et al.
Journal of Medical Economics
|
April 1, 2025
Healthcare resource utilization patterns among patients with Parkinson's disease psychosis and dementia: analysis of US Medicare beneficiaries treated with pimavanserin versus other-atypical antipsychotics or versus quetiapine
Krithika Rajagopalan, Daksha Gopal, Lambros Chrones, et al.
Journal of Medical Economics
|
June 13, 2026
Rett syndrome and real-world treatment patterns of trofinetide in the United States
Nazia Rashid, Vinod Kumar Yakkala, Safiuddin Shoeb Syed, et al.
Journal of Health Economics and Outcomes Research
|
June 15, 2026
Real-World Treatment Landscape of Individuals with Rett Syndrome Treated and Untreated with Trofinetide in the United States
Nazia Rashid, Vinod K Yakkala, Safiuddin S Syed, et al.
Journal of Managed Care & Specialty Pharmacy
|
March 1, 2021
Burden of illness among patients with dementia-related psychosis
Monica Frazer, Victor Abler, Rachel Halpern, et al.
Page
of 7